{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:42:21Z","timestamp":1791394941339,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijcard.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T03:34:25Z","timestamp":1528256065000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study"],"prefix":"10.1016","volume":"270","author":[{"given":"Jean","family":"Ferri\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Lautsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishali M.","family":"Ambegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-0876","authenticated-orcid":false,"given":"Gaetano M.","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl A.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori D.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Velkovski-Rouyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Horack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Almahmeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tien","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-7924","authenticated-orcid":false,"given":"Kian Keong","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0505-078X","authenticated-orcid":false,"given":"Moses","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm K.","family":"Gitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.06.008_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ncpcardio1302","article-title":"Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry","volume":"5","author":"Fox","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"European Association for Cardiovascular Prevention & Rehabilitation","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0030","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.021314","article-title":"Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population","volume":"134","author":"Kaasenbrood","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0035","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/clc.22583","article-title":"Residual ischemic risk and its determinants in patients with previous myocardial infarction and without prior stroke or TIA: insights from the REACH registry","volume":"39","author":"Abtan","year":"2016","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12872-016-0400-6","article-title":"Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome","volume":"16","author":"Ergatoudes","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.acvd.2010.05.003","article-title":"Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization","volume":"103","author":"Tuppin","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0055","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.amjcard.2011.07.038","article-title":"Rate of nuisance bleedings and impact on compliance to prasugrel in acute coronary syndromes","volume":"108","author":"Armero","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/clc.22289","article-title":"Adherence to dual antiplatelet therapy after coronary stenting: a systematic review","volume":"37","author":"Czarny","year":"2014","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22217","article-title":"Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry","volume":"36","author":"Rodriguez","year":"2013","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0070","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0080","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0090","author":"Haute Autorit\u00e9 de sant\u00e9"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.atherosclerosis.2008.09.031","article-title":"Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI)","volume":"204","author":"Ferrieres","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2016.01.018","article-title":"Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries\u2014findings from the EUROASPIRE IV survey","volume":"246","author":"Reiner","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0105","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2047487314547652","article-title":"Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry","volume":"22","author":"Ferrari","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.acvd.2016.11.004","article-title":"Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS\/CHD study","volume":"110","author":"Ferrieres","year":"2017","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0120","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1093\/eurheartj\/suw009","article-title":"Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur. Heart. J. Suppl."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0135","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0140","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of Lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0150","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0155","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"AIM-HIGH Investigators","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0170","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0175","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2006091006","article-title":"Lipoprotein metabolism and lipid management in chronic kidney disease","volume":"18","author":"Kwan","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0180","first-page":"1476","article-title":"Ezetimibe plus a statin after acute coronary syndromes","volume":"373","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0190","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2017.07.783","article-title":"Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction","volume":"70","author":"Korhonen","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0195","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0200","article-title":"HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2013.03.007","article-title":"Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy\u2014a meta-analysis of 11 randomized controlled trials involving 21,295 participants","volume":"72","author":"Barylski","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0210","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0215","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-143-9-200511010-00010","article-title":"Meta-analysis: secondary prevention programs for patients with coronary artery disease","volume":"143","author":"Clark","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011273.pub2","article-title":"Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews","author":"Anderson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2018.06.008_bb0230","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/heartjnl-2014-305783","article-title":"Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial","volume":"100","author":"Varnfield","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.06.008_bb0235","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/heartjnl-2016-310195","article-title":"Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events","volume":"103","author":"Burn","year":"2017","journal-title":"Heart"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318300597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318300597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T05:43:10Z","timestamp":1536730990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318300597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":47,"alternative-id":["S0167527318300597"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.008","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}